Literature DB >> 19199550

Role played by human mannose-binding lectin polymorphisms in pulmonary tuberculosis.

Rosanna Capparelli1, Marco Iannaccone, Daniela Palumbo, Chiara Medaglia, Emilio Moscariello, Alfredo Russo, Domenico Iannelli.   

Abstract

BACKGROUND: Mannose-binding lectin (MBL) activates the complement system in an antibody-independent manner, enhances complement-mediated phagocytosis, and plays a major role in the regulation of inflammatory cytokine release by monocytes.
METHODS: Case patients (277 patients with pulmonary tuberculosis) and control subjects (288 household contacts) were tested by polymerase chain reaction (PCR) for polymorphisms at the promoter and the exon 1 regions of the MBL gene. Diagnosis of pulmonary tuberculosis, based on findings from chest radiography and sputum smear examination, was confirmed by PCR and bacteriological tests.
RESULTS: HYA/HYA subjects were protected against tuberculosis (odds ratio [OR], 0.09 [95% confidence interval {CI}], 0.023-0.408; P < 1 X 10 (-6)). LYB/LYD subjects were susceptible to disease (OR, 49 [95% CI, 2.9-812.5]; P < 1 X 10(-6)).
CONCLUSIONS: This study supports the conclusion that MBL can protect or predispose the host to tuberculosis, depending on the host's haplotype pair.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19199550     DOI: 10.1086/596658

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

1.  Extra-pulmonary tuberculosis: a biomarker analysis.

Authors:  J Fortún; P Martín-Dávila; E Gómez-Mampaso; A Vallejo; C Cuartero; A González-García; J Rubí; E Pallarés; S Moreno
Journal:  Infection       Date:  2014-03-21       Impact factor: 3.553

Review 2.  C-type lectins with a sweet spot for Mycobacterium tuberculosis.

Authors:  G Lugo-Villarino; D Hudrisier; A Tanne; O Neyrolles
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-03

Review 3.  Innate immune gene polymorphisms in tuberculosis.

Authors:  Abul K Azad; Wolfgang Sadee; Larry S Schlesinger
Journal:  Infect Immun       Date:  2012-07-23       Impact factor: 3.441

Review 4.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 5.  Mannose-binding lectin and susceptibility to tuberculosis: a meta-analysis.

Authors:  J T Denholm; E S McBryde; D P Eisen
Journal:  Clin Exp Immunol       Date:  2010-08-19       Impact factor: 4.330

6.  No Strong Relationship Between Components of the Lectin Pathway of Complement and Susceptibility to Pulmonary Tuberculosis.

Authors:  James D Chalmers; Misao Matsushita; David C Kilpatrick; Adam T Hill
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

Review 7.  C-type lectin receptors in tuberculosis: what we know.

Authors:  Surabhi Goyal; Tilman E Klassert; Hortense Slevogt
Journal:  Med Microbiol Immunol       Date:  2016-07-28       Impact factor: 3.402

8.  Deficient serum mannose-binding lectin levels and MBL2 polymorphisms increase the risk of single and recurrent Cryptosporidium infections in young children.

Authors:  Marya Carmolli; Priya Duggal; Rashidul Haque; Janet Lindow; Dinesh Mondal; William A Petri; Phoenix Mourningstar; Catherine J Larsson; Meera Sreenivasan; Salwa Khan; B D Kirkpatrick
Journal:  J Infect Dis       Date:  2009-11-15       Impact factor: 5.226

9.  Genomics of human pulmonary tuberculosis: from genes to pathways.

Authors:  Catherine M Stein; Lindsay Sausville; Christian Wejse; Rafal S Sobota; Nicola M Zetola; Philip C Hill; W Henry Boom; William K Scott; Giorgio Sirugo; Scott M Williams
Journal:  Curr Genet Med Rep       Date:  2017-10-12

Review 10.  Genetic polymorphisms of MBL2 and tuberculosis susceptibility: a meta-analysis of 22 case-control studies.

Authors:  Yan Cao; Xinjing Wang; Zhihong Cao; Chunyan Wu; Dongmei Wu; Xiaoxing Cheng
Journal:  Arch Med Sci       Date:  2017-01-20       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.